BioLineRx Ltd. Equity And Liabilities
BioLineRx Ltd. (BLRX) had Equity And Liabilities of $40.91 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2026-03-23
- 2025-12-31: Equity And Liabilities $40.91M.
- 2025-06-30: Equity And Liabilities $43.27M.
- 2024-12-31: Equity And Liabilities $38.91M.
- 2024-06-30: Equity And Liabilities $64.60M.
| Period end | Equity And Liabilities |
|---|---|
| 2025-12-31 | $40.91M 20-F · filed 2026-03-23 |
| 2025-06-30 | $43.27M 6-K · filed 2025-08-14 |
| 2024-12-31 | $38.91M 20-F · filed 2026-03-23 |
| 2024-06-30 | $64.60M 6-K · filed 2024-08-15 |
| 2023-12-31 | $63.92M 20-F · filed 2025-03-31 |
| 2023-06-30 | $58.94M 6-K · filed 2023-08-30 |
| 2022-12-31 | $76.38M 20-F · filed 2024-03-26 |
| 2022-06-30 | $67.84M 6-K · filed 2022-08-16 |
| 2021-12-31 | $81.39M 20-F · filed 2023-03-22 |
| 2021-06-30 | $91.33M 6-K · filed 2021-08-18 |
| 2020-12-31 | $47.29M 20-F · filed 2022-03-16 |
| 2020-06-30 | $52.99M 6-K · filed 2020-08-06 |
| 2019-12-31 | $53.57M 20-F · filed 2021-02-23 |
| 2019-06-30 | $61.96M 6-K · filed 2019-08-06 |
| 2018-12-31 | $56.23M 20-F · filed 2020-03-12 |
| 2018-06-30 | $52.21M 6-K · filed 2018-08-13 |
| 2017-12-31 | $60.97M 20-F · filed 2019-03-28 |
| 2016-12-31 | $38.94M 20-F · filed 2018-03-06 |